Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL7620822 | 0.70 | ALDH1A1 (0.58) | ALDH1A1KMT2AGAAMAPTP2RX7 | |
| Cyanide SCHEMBL27411534 | 0.70 | ALDH1A1 (0.54) | ALDH1A1KMT2AGAAMAPTP2RX7 | |
| Bicarbonate SCHEMBL9046253 | 0.70 | KMT2A (0.62) | ALDH1A1KMT2AGAAMAPTP2RX7 | |
| Bicarbonate SCHEMBL7615735 | 0.68 | ALDH1A1 (0.64) | ALDH1A1KMT2AGAAMAPTP2RX7 | |
| Bicarbonate SCHEMBL7618943 | 0.68 | ALDH1A1 (0.70) | ALDH1A1KMT2AGAAMAPTP2RX7 | |
| SCHEMBL12851348 | 0.67 | TP53 (0.67) | ALDH1A1KMT2AMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL4299881 | 0.67 | SMN1; SMN2 (0.65) | ALDH1A1KMT2AMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL23619688 | 0.67 | ALDH1A1 (0.69) | ALDH1A1KMT2AMAPTSMN1; SMN2NPSR1 | |
| Bicarbonate SCHEMBL7614611 | 0.67 | ALDH1A1 (0.61) | ALDH1A1KMT2AGAAMAPTP2RX7 | |
| SCHEMBL8907216 | 0.67 | ALDH1A1 (0.50) | ALDH1A1KMT2AGAAMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130085133-A1 | ANTI-VIRAL TREATMENT AND ASSAY TO SCREENFOR ANTI-VIRAL AGENT | Sourthern Research Institute Office of Commercialization and Intellectual Prop. (US) | 2013-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085133-A1 | ANTI-VIRAL TREATMENT AND ASSAY TO SCREENFOR ANTI-VIRAL AGENT | MAVS, SNRPE, LONP1 | ALDH1A1 3082/4885KMT2A 4174/4885GAA 1193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.